Trial intelligence / Profile preview

Balneum Plus vs emollient for uraemic pruritus in haemodialysis patients

2014-005594-36Phase 4Completed

Sponsor
Portsmouth Hospitals University NHS Trust
Start
Nov 2015
Modality
Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of polidocanol + urea in chronic kidney disease-associated pruritus (CKD-aP) (2 arms), sponsored by Portsmouth Hospitals University NHS Trust. Primary endpoint: Reduction in itch intensity. Started Nov 2015; status: completed.

02

Drugs

polidocanol + urea
03

Conditions

chronic kidney disease-associated pruritus (CKD-aP)

Beyond the preview

Go deeper on 2014-005594-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-005594-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call